BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Brain cancer AND TRIM27, DASS-46L4_6, RFP, 5987, ENSG00000234495, RNF76 AND Treatment
15156 results:

  • 1. Dual-targeted delivery of temozolomide by multi-responsive nanoplatform via tumor microenvironment modulation for overcoming drug resistance to treat glioblastoma.
    Chen X; Zheng Y; Zhang Q; Chen Q; Chen Z; Wu D
    J Nanobiotechnology; 2024 May; 22(1):264. PubMed ID: 38760771
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Safety and efficacy of inebilizumab for the treatment of neuromyelitis optica spectrum disorder: end-of-study results from the open-label period of the N-MOmentum trial.
    Cree BAC; Kim HJ; Weinshenker BG; Pittock SJ; Wingerchuk DM; Fujihara K; Paul F; Cutter GR; Marignier R; Green AJ; Aktas O; Hartung HP; She D; Rees W; Smith M; Cimbora D; Katz E; Bennett JL;
    Lancet Neurol; 2024 Jun; 23(6):588-602. PubMed ID: 38760098
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Multi-omic analysis identifies hypoalbuminemia as independent biomarker of poor outcome upon PD-1 blockade in metastatic melanoma.
    Leek LVM; Notohardjo JCL; de Joode K; Velker EL; Haanen JBAG; Suijkerbuijk KPM; Aarts MJB; de Groot JWB; Kapiteijn E; van den Berkmortel FWPJ; Westgeest HM; de Gruijl TD; Retel VP; Cuppen E; van der Veldt AAM; Labots M; Voest EE; van de Haar J; van den Eertwegh AJM
    Sci Rep; 2024 May; 14(1):11244. PubMed ID: 38755213
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
    da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
    Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Understanding supported self-management for people living with a lower-grade glioma: Implementation considerations through the lens of normalisation process theory.
    Rimmer B; Finch T; Balla M; Dutton L; Williams S; Lewis J; Gallagher P; Burns R; Araújo-Soares V; Menger F; Sharp L;
    Health Expect; 2024 Jun; 27(3):e14073. PubMed ID: 38733245
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Artificial neural network identified a 20-gene panel in predicting immunotherapy response and survival benefits after anti-PD1/PD-L1 treatment in glioblastoma patients.
    Wang Y; Wang Z; Guo X; Cao Y; Xing H; Wang Y; Xing B; Wang Y; Yao Y; Ma W
    Cancer Med; 2024 May; 13(9):e7218. PubMed ID: 38733169
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Preoperative peripheral inflammatory markers are predictors of postoperative central diabetes insipidus in craniopharyngioma patients: a retrospective study.
    Wang J; Wang G; Cheng L; Zhu H; Wang J; Ding X; Niu H; Zhao K; Shu K
    BMC Cancer; 2024 May; 24(1):572. PubMed ID: 38720306
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Metabolome-associated psychological comorbidities improvement in irritable bowel syndrome patients receiving a probiotic.
    Martin FP; Cominetti O; Berger B; Combremont S; Marquis J; Xie G; Jia W; Pinto-Sanchez MI; Bercik P; Bergonzelli G
    Gut Microbes; 2024; 16(1):2347715. PubMed ID: 38717445
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Clinical characteristics and prognostic factors of adult brainstem gliomas: A retrospective analysis of histologically-proven 40 cases.
    Li S; Zhao Y; Huang H
    Medicine (Baltimore); 2024 May; 103(18):e37910. PubMed ID: 38701282
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Early therapy evaluation of intra-arterial trastuzumab injection in a human breast cancer xenograft model using multiparametric MR imaging.
    Kim BK; Kim B; You SH; Jang MS; Im GH; Kim KH
    PLoS One; 2024; 19(5):e0300171. PubMed ID: 38701062
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. The Father of Wisdom: "The Influence of Surgical Experience on Overall Survival in Patients with Malignant Gliomas".
    Florian IS; Beni L; Andrasoni Z; Aldea C; Florian IA
    Adv Tech Stand Neurosurg; 2024; 49():181-200. PubMed ID: 38700685
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Investigation of high-dose radiotherapy's effect on brain structure aggravated cognitive impairment and deteriorated patient psychological status in brain tumor treatment.
    Ma J; Cao H; Hou D; Wang W; Liu T
    Sci Rep; 2024 May; 14(1):10149. PubMed ID: 38698048
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Tebentafusp in the treatment of metastatic uveal melanoma - the first patient treated in the Czech Republic.
    Klabusay M; Bábková B
    Klin Onkol; 2024; 38(2):134-138. PubMed ID: 38697822
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. MOG Antibody-Associated Disease in the Setting of Metastatic Melanoma Complicated by Immune Checkpoint Inhibitor Use.
    Syc-Mazurek SB; Zhao-Fleming H; Guo Y; Tisavipat N; Chen JJ; Zekeridou A; Kournoutas I; Orme JJ; Block MS; Lucchinetti CF; Mustafa R; Flanagan EP
    Neurol Neuroimmunol Neuroinflamm; 2024 Jul; 11(4):e200249. PubMed ID: 38696737
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. The effects of alcohol use on smoking cessation treatment with nicotine replacement therapy: An observational study.
    Wong BKC; Veldhuizen S; Minian N; Zawertailo L; Selby P
    Addict Behav; 2024 Aug; 155():108045. PubMed ID: 38692071
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Safety and Tolerability of Online Adaptive High-Field Magnetic Resonance-Guided Radiotherapy.
    Westerhoff JM; Daamen LA; Christodouleas JP; Blezer ELA; Choudhury A; Westley RL; Erickson BA; Fuller CD; Hafeez S; van der Heide UA; Intven MPW; Kirby AM; Lalondrelle S; Minsky BD; Mook S; Nowee ME; Marijnen CAM; Orrling KM; Sahgal A; Schultz CJ; Faivre-Finn C; Tersteeg RJHA; Tree AC; Tseng CL; Schytte T; Silk DM; Eggert D; Luzzara M; van der Voort van Zyp JRN; Verkooijen HM; Hall WA
    JAMA Netw Open; 2024 May; 7(5):e2410819. PubMed ID: 38691356
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Case report: Temozolomide induced hypermutation indicates an unfavorable response to immunotherapy in patient with gliomas.
    Liu J; Hu S; Jiang H; Cui Y
    Front Immunol; 2024; 15():1369972. PubMed ID: 38690285
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. [Analysis of clinical manifestations and imaging features of facial nerve schwannomas].
    Han Y; Liu H; Yang R; Li R; Liu X; Wang W; Zhang J; Dong J; Zha D
    Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi; 2024 May; 38(5):380-385. PubMed ID: 38686473
    [No Abstract]    [Full Text] [Related]  

  • 19. Predictors of salvage therapy for parasagittal meningiomas treated with primary surgery, radiosurgery, or surgery plus adjuvant radiotherapy.
    Joy Trybula S; Nandoliya KR; Youngblood MW; Karras CL; Fernandez LG; Oyon DE; Texakalidis P; Khan OH; Lesniak MS; Tate MC; Rosenow JM; Hill VB; Hijaz TA; Russell EJ; Sachdev S; Kalapurakal JA; Horbinski CM; Magill ST; Chandler JP
    J Clin Neurosci; 2024 Jun; 124():102-108. PubMed ID: 38685181
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Prediction of the treatment response and local failure of patients with brain metastasis treated with stereotactic radiosurgery using machine learning: A systematic review and meta-analysis.
    Habibi MA; Rashidi F; Habibzadeh A; Mehrtabar E; Arshadi MR; Mirjani MS
    Neurosurg Rev; 2024 Apr; 47(1):199. PubMed ID: 38684566
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 758.